Formulation And Evaluation Of Pharmaceutical Emulgel With Indomethacin And Azadirachta Indica For Enhanced Analgesic And Anti-Inflammatory Effects
Keywords:
Pharmaceutical emulgel, Indomethacin, Azadirachta indica, Nimbidin, anti-inflammatory, analgesicAbstract
Topical delivery systems such as emulgels offer a promising approach for the treatment of localized inflammation and pain by enhancing drug permeation and minimizing systemic side effects. Indomethacin, a potent NSAID, has limited water solubility and gastrointestinal side effects when administered orally. Azadirachta indica (Nimbidin) is a natural anti-inflammatory and antimicrobial agent known for its therapeutic potential. This study aimed to formulate and evaluate an emulgel incorporating Indomethacin and Azadirachta indica for enhanced analgesic and anti-inflammatory activity. Nimbidin was extracted from neem seeds using cold press and Soxhlet extraction methods. Emulgels were prepared using Carbopol 934 as a gelling agent and Span 80/Tween 80 as emulsifiers. The formulations were evaluated for physical appearance, pH, viscosity, spreadability, drug content, in vitro drug release, antimicrobial activity, skin irritation, and stability under accelerated conditions. The optimized formulation (F2) demonstrated desirable pH (5.9), viscosity (52,000 cps), and excellent spreadability. Drug content was within acceptable limits (Indomethacin: 98.4%, Nimbidin: 97.2%). In vitro release studies showed sustained drug release (94.1% over 8 hours). Antimicrobial activity and skin safety were confirmed. Stability studies indicated good retention of physical and chemical properties. The developed emulgel combining Indomethacin and Azadirachta indica exhibited enhanced therapeutic efficacy, favorable stability, and excellent topical tolerability, indicating its potential as an effective treatment for inflammatory and painful skin conditions.
Downloads
References
A. Chandel, N. Kumari, R. Gupta, A. Nazir, H. Honey, and A. C. Varghese, “An Overview on Emulgel,” Asian J. Pharm. Res., 2023, doi: 10.52711/2231-5691.2023.00037.
N. Datta et al., “Formulation and Evaluation of Topical Nano Emulgel of Adapalene,” Sch. Acad. J. Pharm., 2020.
A. D. Kandhare, A. A. Mukherjee, and S. L. Bodhankar, “Neuroprotective effect of Azadirachta indica standardized extract in partial sciatic nerve injury in rats: Evidence from anti-inflammatory, antioxidant and anti-apoptotic studies,” EXCLI J., 2017, doi: 10.17179/excli2017-161.
A. Bhattacharya, D. Agrawal, P. Das, B. Rath, S. Kumar, and S. Patnaik, “Analgesic effect of azadirachta indica (Neem) leaf extract on albino rats,” Pharmacologyonline, 2014.
A. Eid, N. Jaradat, and N. Elmarzugi, “A Review of chemical constituents and traditional usage of Neem plant (Azadirachta Indica),” Palest. Med. Pharm. J., 2017, doi: 10.59049/2790-0231.1060.
R. N. Kharwar et al., “Harnessing the phytotherapeutic treasure troves of the ancient medicinal plant azadirachta indica (Neem) and associated endophytic microorganisms,” 2020. doi: 10.1055/a-1107-9370.
I. K. Burki, M. K. Khan, B. A. Khan, B. Uzair, V. A. Braga, and Q. A. Jamil, “Formulation Development, Characterization, and Evaluation of a Novel Dexibuprofen-Capsaicin Skin Emulgel with Improved In Vivo Anti-inflammatory and Analgesic Effects,” AAPS PharmSciTech, 2020, doi: 10.1208/s12249-020-01760-7.
A. S. Mali et al., “Antinociceptive and antioxidant activities of methanolic extract of leaves of Azadirachta Indica (Neem),” bioRxiv, 2019.
N. Khanna, M. Goswami, P. Sen, and A. Ray, “Antinociceptive action of Azadirachta indica (Neem) in mice: Possible mechanisms involved,” Indian J. Exp. Biol., 1995.
B. A. Khan et al., “Fabrication and Characterizations of Pharmaceutical Emulgel Co-Loaded with Naproxen-Eugenol for Improved Analgesic and Anti-Inflammatory Effects,” Gels, 2022, doi: 10.3390/gels8100608.
F. Ghanbarveisi, Z. Pourmanouchehri, S. Khaledian, and L. Behbood, “Formulation and evaluation of emulgel containing Sucralfate and Dimethicone; A novel transdermal pharmaceutical dosage form,” J. Res. Pharm., 2022, doi: 10.29228/jrp.208.
А. Soloviova, О. Kaliuzhnaia, O. Strilets, D. Lytkin, and O. Goryacha, “THE MAIN STAGES OF PHARMACEUTICAL DEVELOPMENT OF EMULGEL ‘PROBIOSKIN,’” Sci. Pharm. Sci., 2021, doi: 10.15587/2519-4852.2021.249710.
O. D. Bamidele, O. M. Adegbolagun, H. G. Subair, and B. O. Emikpe, “In-vivo anti-plasmodial activity of mama decoction® with or without paracetamol in mice,” African J. Biomed. Res., 2019.
N. R. Charyulu, P. Joshi, A. Dubey, and A. Shetty, “Emulgel: A Boon for Enhanced Topical Drug Delivery,” J. Young Pharm., 2021, doi: 10.5530/jyp.2021.13.17.
U. Kumar Vandana, J. Hansa, S. Kumar, and D. Agrawal, “Analgesic, Anti-inflammatory and Anti-Pyretic Effects of Azadirachta indica (Neem) Leaf Extract in Albino Rats,” Artic. Int. J. Sci. Res., 2015.
V. A. Echanur et al., “Continuous Manufacturing of Oil in Water (O/W) Emulgel by Extrusion Process,” AAPS PharmSciTech, 2023, doi: 10.1208/s12249-023-02530-x.
S. Kumar, U. Kumar Vandana, D. Agrawal, and J. Hansa, “Analgesic, Anti-inflammatory and Anti-Pyretic Effects of Azadirachta indica (Neem) Leaf Extract in Albino Rats,” 2013.
A. Nayak, S. K. Mandal, M. A. Ramadan, and S. K. Rath, “Formulation, development and physicochemical characterization of diclofenac topical emulgel,” Egypt. J. Chem., 2021, doi: 10.21608/EJCHEM.2021.58467.3259.
S. Malavi, P. Kumbhar, A. Manjappa, J. Disouza, and J. Dwivedi, “Emulgel for improved topical delivery of Tretinoin: Formulation design and characterization,” Ann. Pharm. Fr., 2022, doi: 10.1016/j.pharma.2021.05.004.
S. Paliwal and G. Kaur, “FORMULATION AND CHARACTERIZATION OF TOPICAL NANO EMULGEL OF TERBINAFINE,” Univers. J. Pharm. Res., 2019, doi: 10.22270/ujpr.v3i6.223.
K. Meghna, S. C, S. P, S. KS, and T. C, “American Journal of Biological and Pharmaceutical Research Formulation and Evaluation of Celecoxib Emulgel for Topical Delivery,” Am. J. Biol. Pharm. Res., 2017.
J. Ahmad, A. Gautam, S. Komath, M. Bano, A. Garg, and K. Jain, “Topical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization,” Recent Pat. Antiinfect. Drug Discov., 2018, doi: 10.2174/1574891x14666181129115213.
N. A. Thombre, P. S. Niphade, E. D. Ahire, and S. J. Kshirsagar, “Formulation Development and Evaluation of Microemulsion Based Lornoxicam Gel,” Biosci. Biotechnol. Res. Asia, 2022, doi: 10.13005/bbra/2968.
G. VISHWAKARMA and A. SINGH PANWAR, “EMULGEL EMERGENT SYSTEMS: AT A GLANCE FOR TOPICAL DRUG DELIVERY,” Asian J. Pharm. Clin. Res., 2022, doi: 10.22159/ajpcr.2022.v15i3.43876.
S. K. Sah, A. Badola, and B. K. Nayak, “Emulgel: Magnifying the application of topical drug delivery,” Indian J. Pharm. Biol. Res., 2017, doi: 10.30750/ijpbr.5.1.4.
V. R. Mahajan and G. D. Basarkar, “Formulation design, development and characterization of dexibuprofen emulgel for topical delivery: In-vitro and In-vivo evaluation,” J. Drug Deliv. Ther., 2019.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
